Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGAV | P06756 | 20/20 | 0.53 |
| ▸ | ITGB3 | P05106 | 18/20 | 0.53 |
| ▸ | ITGB6 | P18564 | 9/20 | 0.53 |
| ▸ | ITGB5 | P18084 | 8/20 | 0.53 |
| ▸ | ITGB1 | P05556 | 3/20 | 0.53 |
| ▸ | ITGB8 | P26012 | 1/20 | 0.48 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31445457 | 0.86 | ITGAV (0.50) | ITGAVITGB3ITGB6ITGB5ITGB1 | |
| SCHEMBL20140131 | 0.84 | ITGAV (0.58) | ITGAVITGB3ITGB6ITGB5ITGB1 | |
| SCHEMBL20141075 | 0.84 | ITGAV (0.58) | ITGAVITGB3ITGB6ITGB5ITGB1 | |
| SCHEMBL20158194 | 0.80 | ITGAV (0.56) | ITGAVITGB3ITGB6ITGB5ITGB1 | |
| SCHEMBL760607 | 0.78 | ITGB3 (0.69) | ITGAVITGB3ITGB6ITGB5ITGB1 | |
| SCHEMBL20157754 | 0.78 | ITGB3 (0.59) | ITGAVITGB3ITGB5ITGB1ITGA2B | |
| SCHEMBL20141425 | 0.77 | ITGAV (0.54) | ITGAVITGB3ITGB6ITGB5ITGB1 | |
| SCHEMBL31446088 | 0.77 | CXCR4 (0.45) | ITGAVITGB3ITGB6ITGB5ITGB1 | |
| SCHEMBL23308978 | 0.76 | ITGAV (0.44) | ITGAVITGB3ITGB6ITGB5ITGB1 | |
| SCHEMBL6262063 | 0.76 | ITGB3 (0.74) | ITGAVITGB3ITGB6ITGB5ITGB8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072539-A1 | AMINO ACID COMPOUNDS WITH NITROGEN LINKERS AND USES THEREOF | PLIANT THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |